CA19-9 Cancer Antigen

<strong>CA19-9 Cancer Antigen</strong>_x000D_ <strong>Catalog number:</strong> B2013231_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 kU_x000D_ <strong>Molecular Weight or Concentration:</strong> 100 KU/mL_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20° C_x000D_ <strong>Keywords:</strong> CA19-9_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Scarà S, Bottoni P, Scatena R. CA 19-9: Biochemical and Clinical Aspects Adv Exp Med Biol. 2015;867:247-60._x000D_ 2: Rao H, Wu H, Huang Q, Yu Z, Zhong Z. Clinical Value of Serum CEA, CA24-2 and CA19-9 in Patients with Colorectal Cancer Clin Lab. 2021 Apr 1;67(4)._x000D_ 3: Shibata C, Nakano T, Yasumoto A, Mitamura A, Sawada K, Ogawa H, Miura T, Ise I, Takami K, Yamamoto K, Katayose Y. Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer BMC Surg. 2022 Jun 3;22(1):213._x000D_ 4: Lertkhachonsuk AA, Buranawongtrakoon S, Lekskul N, Rermluk N, Wee-Stekly WW, Charakorn C. Serum CA19-9, CA-125 and CEA as tumor markers for mucinous ovarian tumors J Obstet Gynaecol Res. 2020 Nov;46(11):2287-2291._x000D_ 5: Kawamura H, Honda M, Takano Y, Kinuta S, Kamiga T, Saji S, Kono K. Prognostic Role of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 in Stage IV Colorectal Cancer Anticancer Res. 2022 Aug;42(8):3921-3928._x000D_ 6: Luo G, Guo M, Jin K, Liu Z, Liu C, Cheng H, Lu Y, Long J, Liu L, Xu J, Ni Q, Yu X. Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping Pancreatology. 2016 Nov-Dec;16(6):1057-1062._x000D_ 7: Suehiro Y, Suenaga S, Kunimune Y, Yada S, Hamamoto K, Tsuyama T, Amano S, Matsui H, Higaki S, Fujii I, Suzuki C, Hoshida T, Matsumoto T, Fujimoto Y, Kaino S, Shinjo K, Kondo Y, Sakaida I, Takami T, Nagano H, Yamasaki T. CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic Cancer Oncology. 2022;100(12):674-684._x000D_ 8: Demirli Atici S, Kamer E. Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer? World J Gastroenterol. 2022 Jan 28;28(4):500-501._x000D_ 9: Moriyama J, Oshima Y, Nanami T, Suzuki T, Yajima S, Shiratori F, Funahashi K, Shimada H. Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer Surg Today. 2021 Oct;51(10):1638-1648._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/7846014">10: Gullo L. CA19-9: the Italian experience Pancreas. 1994 Nov;9(6):717-9.</a>_x000D_ _x000D_ <strong>Products Related to CA19-9 Cancer Antigen can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>